Concepedia

Publication | Open Access

Addition of Gemtuzumab Ozogamicin to Induction Chemotherapy Improves Survival in Older Patients With Acute Myeloid Leukemia

DOIFull Paper Access

402

Citations

19

References

2012

Year

Alan K. Burnett, Nigel H. Russell, Robert K. Hills, Jonathan Kell, Sylvie Freeman, Lars Kjeldsen, Ann E. Hunter, John Yin, Charles Craddock, Inge Høgh Dufva,
Journal of Clinical Oncology

Abstract

Adding GO (3 mg/m(2)) to induction chemotherapy reduces relapse risk and improves survival with little increase in toxicity.

References

YearCitations

Page 1